The Immune System as Anti-Cancer Therapy

This course will discuss the biology, rationale and preclinical development of chimeric antigen receptor (CAR) modified T cells as an anti-cancer therapy, current results and future applications in cancer immunotherapy. 

Target Audience

Pediatricians, Pediatric Oncologists, Hematologists/Oncologists, Infectious Disease Pediatricians, Pediatric General Internists, Family Physicians, Neonatologists, Respiratory Therapists, Pharmacists and Emergency Department Physicians. 

Learning Objectives

  • Explain the biology, rationale and preclinical development of chimeric antigen receptor (CAR) T cells. 
  • Assess the current results using CAR T cells for relapsed/refractory B-ALL. 
  • Describe the future application of CAR T cells in cancer immunotherapy. 
Additional information
Bibliography: 
  • Curran, Kevin J., Brentjens, Reinier, J. (2015). Chimeric antigent Receptor T Cells for Cancer Immunotherapy. Journal of Clinical Oncology, May 20;33 (15):1703-6.
Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Florida Board of Pharmacy
  • 0.50 Florida Board of Respiratory Therapy
  • 0.75 General certificate of attendance
Course opens: 
02/01/2018
Course expires: 
02/01/2020

Kevin J. Curran, M.D.
Assistant Attending, BMT Service
Department of Pediatrics 
Memorial Sloan Kettering Cancer Center
New York, New York

Kevin J. Curran, M.D., has indicated that he has received grant/research support from Juno Therapeutic and is a consultant for Novartis and he will not include off-label or unapproved product usage in his presentation or discussion.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

Disclosure Policy and Disclaimer 

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
              
Baptist Health South Florida designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Florida Board of Pharmacy
  • 0.50 Florida Board of Respiratory Therapy
  • 0.75 General certificate of attendance

Accreditation Period

Course opens: 
02/01/2018
Course expires: 
02/01/2020
Please login or register to take this course.

Required Hardware/software

This site is best viewed on the two most recent stable releases of the following browsers for all public pages:

PCs Running Windows

  • Google Chrome (Preferred): Download free web browser for PC, Mac, phone and tablet. 
  • Internet Explorer (IE 11 and above recommended): You will be prompted to download videos before you are able to view. Click “download” to view video.  After a momentary pause, the recording will play. 
  • Mozilla Firefox: You may be prompted under the “This Connection is Untrusted” screen to add “cmeonline.baptisthealth.net” and “cdn.baptisthealth.net” under “add exceptions”.

Apple Computers Running OSX

This site uses a responsive design, which allows the page layout of elements to change depending on the screen resolution. Certain functionality may change based on the screen resolution of smaller screens, such as the number of columns in a table.

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.